F. Biron

1.5k total citations
42 papers, 530 citations indexed

About

F. Biron is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, F. Biron has authored 42 papers receiving a total of 530 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Infectious Diseases, 16 papers in Epidemiology and 14 papers in Virology. Recurrent topics in F. Biron's work include HIV Research and Treatment (13 papers), HIV/AIDS drug development and treatment (8 papers) and HIV/AIDS Research and Interventions (6 papers). F. Biron is often cited by papers focused on HIV Research and Treatment (13 papers), HIV/AIDS drug development and treatment (8 papers) and HIV/AIDS Research and Interventions (6 papers). F. Biron collaborates with scholars based in France and Morocco. F. Biron's co-authors include D. Peyramond, A. Boibieux, Bernard Verrier, Yasemin Ataman‐Önal, Françis Barin, Tristan Ferry, Christian Chidiac, Emmanuel Drouet, B. Ponceau and Alain Moreau and has published in prestigious journals such as Journal of Virology, The Journal of Infectious Diseases and Intensive Care Medicine.

In The Last Decade

F. Biron

40 papers receiving 513 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. Biron France 12 245 175 168 65 63 42 530
John T. Carey United States 11 439 1.8× 120 0.7× 401 2.4× 66 1.0× 75 1.2× 18 791
P. Morlat France 10 204 0.8× 175 1.0× 158 0.9× 31 0.5× 99 1.6× 36 440
George McKinley United States 12 227 0.9× 219 1.3× 389 2.3× 27 0.4× 30 0.5× 28 644
A Terragna Italy 15 177 0.7× 101 0.6× 318 1.9× 56 0.9× 135 2.1× 46 676
Marie‐Caroline Meyohas France 17 399 1.6× 118 0.7× 614 3.7× 65 1.0× 45 0.7× 45 913
Moses Kapembwa United Kingdom 18 266 1.1× 208 1.2× 292 1.7× 62 1.0× 26 0.4× 35 824
E Dournon France 12 241 1.0× 150 0.9× 221 1.3× 57 0.9× 49 0.8× 55 661
Jacques Gilquin France 13 447 1.8× 428 2.4× 315 1.9× 48 0.7× 34 0.5× 33 963
Kathryn Dupnik United States 14 393 1.6× 93 0.5× 194 1.2× 81 1.2× 97 1.5× 34 580
Muriel Alvarez France 14 326 1.3× 58 0.3× 285 1.7× 108 1.7× 31 0.5× 24 563

Countries citing papers authored by F. Biron

Since Specialization
Citations

This map shows the geographic impact of F. Biron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Biron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Biron more than expected).

Fields of papers citing papers by F. Biron

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Biron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Biron. The network helps show where F. Biron may publish in the future.

Co-authorship network of co-authors of F. Biron

This figure shows the co-authorship network connecting the top 25 collaborators of F. Biron. A scholar is included among the top collaborators of F. Biron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Biron. F. Biron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Valour, Florent, A. Boibieux, Judith Karsenty, et al.. (2016). Pristinamycin in the treatment of MSSA bone and joint infection. Journal of Antimicrobial Chemotherapy. 71(4). 1063–1070. 5 indexed citations
2.
Catho, Gaud, S. Couraud, S. Grard, et al.. (2015). Management of emerging multidrug-resistant tuberculosis in a low-prevalence setting. Clinical Microbiology and Infection. 21(5). 472.e7–472.e10. 4 indexed citations
3.
Tringali, S., et al.. (2009). Monoarthrite à Streptococcus pyogenes dans les suites d’une septoplastie : intérêt de la décontamination nasale en préopératoire. Médecine et Maladies Infectieuses. 40(9). 548–551. 1 indexed citations
4.
Valour, Florent, Laurence Maulin, Florence Ader, et al.. (2006). Vaccination contre la grippe : résultats d'une enquête sur la couverture vaccinale du personnel hospitalier à l'hôpital de la Croix-Rousse (hôpitaux de Lyon). Médecine et Maladies Infectieuses. 37(1). 51–60. 17 indexed citations
5.
Guillon, Christophe, K. Stankovic, Yasemin Ataman‐Önal, F. Biron, & Bernard Verrier. (2006). Evidence for CTL-Mediated Selection of Tat and Rev Mutants after the Onset of the Asymptomatic Period during HIV Type 1 Infection. AIDS Research and Human Retroviruses. 22(12). 1283–1292. 17 indexed citations
6.
Ferry, Tristan, B. Ponceau, M. A. Piens, et al.. (2005). Disseminated cryptococcosis and histoplasmosis co-infection in a HIV-infected woman in France. Journal of Infection. 51(3). e173–e176. 11 indexed citations
7.
Ferry, Tristan, B. Ponceau, B. Issartel, et al.. (2005). Possibly Linezolid-Induced Peripheral and Central Neurotoxicity: Report of Four Cases. Infection. 33(3). 151–154. 50 indexed citations
8.
Giard, Marine, A. Boibieux, B. Ponceau, et al.. (2005). Interruption thérapeutique chez des patients infectés par le virus de l'immunodéficience humaine : évolution clinique et biologique. Médecine et Maladies Infectieuses. 35(11). 525–529. 3 indexed citations
9.
Vachot, Laurence, et al.. (2004). Short Communication: Retrospective Study to Time the Introduction of HIV Type 1 Non-B Subtypes in Lyon, France, Using env Genes Obtained from Primary Infection Samples. AIDS Research and Human Retroviruses. 20(7). 687–691. 11 indexed citations
10.
Sève, P., A. Boibieux, Damien Bouhour, et al.. (2001). Les ostéomyélites du pubis de l’athlète. La Revue de Médecine Interne. 22(6). 576–581. 11 indexed citations
11.
Biron, F., et al.. (2000). Long-Term Safety and Antiretroviral Activity of Hydroxyurea and Didanosine in HIV-Infected Patients. JAIDS Journal of Acquired Immune Deficiency Syndromes. 25(4). 329–336. 15 indexed citations
12.
Chaumentin, G., Thierry Zénone, G Denoyel, et al.. (1997). Malignant boutonneuse fever and polymyalgia rheumatica: A coincidental association?. Infection. 25(5). 320–322. 5 indexed citations
13.
Biron, F., D. Peyramond, A. Frésard, et al.. (1996). Pilot clinical trial of the combination of hydroxyurea and didanosine in HIV-1 infected individuals. Antiviral Research. 29(1). 111–113. 23 indexed citations
14.
Biron, F., et al.. (1996). Treatment of 112 bone and joint infections with teicoplanin. European Journal of Orthopaedic Surgery & Traumatology. 6(2). 109–113. 3 indexed citations
15.
Drouet, Emmanuel, Pierre Brousset, A. Boibieux, et al.. (1995). Measurement by the polymerase chain reaction of the Epstein‐Barr virus load in infectious mononucleosis and AIDS‐related non‐Hodgkin's lymphomas. Journal of Medical Virology. 46(1). 66–74. 53 indexed citations
16.
Cozon, G., et al.. (1994). Secretory IgA Antibodies to Cryptosporidium parvum in AIDS patients with Chronic Cryptosporidiosis. The Journal of Infectious Diseases. 169(3). 696–699. 35 indexed citations
17.
Claudel, Jean-Philippe, et al.. (1993). [Diagnosis of acute infectious epidural inflammation. Role of magnetic resonance imaging].. PubMed. 22(9). 425–8. 3 indexed citations
18.
Cozon, G., et al.. (1992). Cryptosporidium parvum sporozoite staining by propidium iodide. International Journal for Parasitology. 22(3). 385–389. 11 indexed citations
19.
Dumontet, Charles, et al.. (1991). Acute Silicosis Due to Inhalation of a Domestic Product. American Review of Respiratory Disease. 143(4_pt_1). 880–882. 16 indexed citations
20.
Salord, F, Bernard Allaouchiche, P Gaussorgues, et al.. (1991). Severe falciparum malaria (21 cases). Intensive Care Medicine. 17(8). 449–454. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John T. Carey Breakdown of academic impact, for papers by P. Morlat Breakdown of academic impact, for papers by George McKinley Breakdown of academic impact, for papers by A Terragna Breakdown of academic impact, for papers by Marie‐Caroline Meyohas Breakdown of academic impact, for papers by Moses Kapembwa Breakdown of academic impact, for papers by E Dournon Breakdown of academic impact, for papers by Jacques Gilquin Breakdown of academic impact, for papers by Kathryn Dupnik Breakdown of academic impact, for papers by Muriel Alvarez
Rankless by CCL
2026